Accès libre

Clinicopathologic Profile and Outcome of Extranodal Diffuse Large B-Cell NHL: Egyptian National Cancer Institute Experience

À propos de cet article

Citez

1] Harris NL (2001) Mature B-cell neoplasms In: WHO Classification of Tumors: Pathology and Genetics of Tumors of Hematopoietic and Lymphoid Tissues, Jaffe EJ, Harris NL, Stein H et al. (eds), Lyon, France, IARC Press, p 121- 126Search in Google Scholar

[2] Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, et al. Cancer statistics, 2004. CA Cancer J Clin 2004;54:8-2910.3322/canjclin.54.1.814974761Search in Google Scholar

[3] Groves FD, Linet MS, Travis LB, et al (2000) Cancer surveillance series: Non-Hodgkin’s lymphoma incidence by histologic subtype in the United States from 1978 through 1995. J Natl Cancer Inst 92:1240-1251.10.1093/jnci/92.15.124010922409Search in Google Scholar

[4] Mokhtar N, Gouda I, and Adel I (2007) Lymphoma in: Cancer Registry 2003-2004, p 36.Search in Google Scholar

[5] Hans CP, Weisenburger DD, Greiner TC, et al. (2004) Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood; 103:275-282.10.1182/blood-2003-05-154514504078Search in Google Scholar

[6] Krol ADG, leCessie S, and Snijder S (2003) Primary extranodal non-Hodgkin’s lymphoma (NHL): The impact of alternative definitions tested in the Comprehensive Cancer Center West populationbased NHL registry. Ann Oncol; 14; 131-9.10.1093/annonc/mdg00412488305Search in Google Scholar

[7] Lossos IS, Czerwinsli DK, Alizadeh AA et al. (2004) Prediction of survival in diffuse large B-cell lymphoma based on the expression of six genes. N Engl J Med; 350:1828-3710.1056/NEJMoa03252015115829Search in Google Scholar

[8] Pileri SA, Dimhofer S, Went Ph, et al. (2002) Diffuse large B-cell lymphoma: One or more entities? Present controversies and possible tools for its subclassification. Histopathology; 41:482-509.10.1046/j.1365-2559.2002.01538.x12460202Search in Google Scholar

[9] Rosenwald A, Wright G, Chan WC, et al (2002) The use of molecular profiling to predict survival after chemotherapy for diffuse large B-cell lymphoma. N Engl J Med; 346:1937-1947.10.1056/NEJMoa01291412075054Search in Google Scholar

[10] McClintock S, Perkins SL, Cleveland RP, et al. (2003) Immunohistochemical expression pattern of germinal center and activation B-cell markers correlates with prognosis in diffuse large B-cell lymphoma. Mod Pathol; 16:244.Search in Google Scholar

[11] Colomo L, Lopez-Guillermo A, Perales M, et al. (2003) Clinical impact of the differentiation profile assessed by immunophenotyping in patients with diffuse large B-cell lymphoma. Blood; 101:78-84.10.1182/blood-2002-04-128612393466Search in Google Scholar

[12] Linderoth J, Jerkeman M, Cavallin-Stahl E, Kvaloy S, Torlakovic E. (2003) Immunohistochemical expression of CD23 and CD40 may identify prognosticallyfavorable subgroups of diffuse large B-cell lymphoma: a Nordic Lymphoma Group Study. Clin Cancer Res; 9:722-728.Search in Google Scholar

[13] Barrans SL, Carter I, Owen RG, et al. Germinal center phenotype and bcl-2 expression combined with the International Prognostic Index improves patient risk stratification in diffuse large B-cell lymphoma. Blood; 99:1136-1143.10.1182/blood.V99.4.113611830458Search in Google Scholar

[14] Lopez-Guillermo A, Colomo L, Jimenez M, et al. (2005) Diffuse large B-cell lymphoma: clinical and biological characterization and outcome according to the nodal or extranodal primary origin. Journal of Clinical Oncology, 23; 2797.10.1200/JCO.2005.07.15515728226Search in Google Scholar

[15] Negri E, Little D, Boiocchi M, et al. (2004) B-cell non-Hodgkin’s lymphoma and hepatitis C virus infection: A systematic review. International Journal of Cancer; 111:1-8.10.1002/ijc.2020515185336Search in Google Scholar

[16] Lal A, Bhurgri Y, Vaziri I, Rizvi NB, et al. (2008) Extranodal Non-Hodgkin’s Lymphomas - A retrospective review of clinicopathologic features and outcomes in comparison with nodal non- Hodgkin lymphomas. Asian Pacific Journal of Cancer Prevention; 9:453. Search in Google Scholar

eISSN:
1792-362X
Langue:
Anglais
Périodicité:
4 fois par an
Sujets de la revue:
Medicine, Clinical Medicine, Internal Medicine, Haematology, Oncology